Capstan Therapeutics
USEntry
2022
Hold
3yr
Exit
2025
Who owns Capstan Therapeutics?
Capstan Therapeutics was owned by Leaps by Bayer through Leaps by Bayer (2015 vintage) from 2022 to 2025, exited via Trade Sale. Across its history, Capstan Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.
Buyer identity available on Pro.
Hand-verified · updated 2026-04-21
Most recent investor
Leaps by BayerLeaps by Bayer · 2015 · Evergreen
2 ownership periods · full history below
Key facts
HQUSA
SectorBiotech
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2022 · present
Mubadala CapitalActive
2022 · present(4yr) · Mubadala Capital Other Investments · Buyout
More from Leaps by Bayer
Other portfolio companies in the same fund.
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Track Capstan Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Capstan Therapeutics?
7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Capstan Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue